Dermal Versus Intraparenchymal Lymphoscintigraphy of the Breast

[1]  C. V. D. van de Velde,et al.  Sentinel lymph node biopsy in breast cancer. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  I. Khalkhali,et al.  Sentinel Node Localization in Breast Cancer , 2001 .

[3]  A. Giuliano,et al.  Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  P. V. van Diest,et al.  Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method. , 2000, Annals of surgery.

[5]  K. Kern,et al.  Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. , 1999, Journal of the American College of Surgeons.

[6]  L. Mariani,et al.  The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. , 1999, European journal of cancer.

[7]  R. Roumen,et al.  In search of the true sentinel node by different injection techniques in breast cancer patients. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  C. O'brien,et al.  Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. , 1999, Journal of the American College of Surgeons.

[9]  H. Cody,et al.  Intradermal Radiocolloid and Intraparenchymal Blue Dye Injection Optimize Sentinel Node Identification in Breast Cancer Patients , 1999, Annals of Surgical Oncology.

[10]  S. Korourian,et al.  Subareolar versus peritumoral injection for location of the sentinel lymph node. , 1999, Annals of surgery.

[11]  Liesbeth Jansen,et al.  Lymphatic mapping and sentinel lymph node biopsy in breast cancer , 1999, European Journal of Nuclear Medicine.

[12]  F W van der Ent,et al.  Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  A. Luini,et al.  Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Liani,et al.  Erythropoietin and thrombotic events , 1998, The Lancet.

[15]  John F. Thompson,et al.  Sentinel-lymph node biopsy in breast cancer , 1998, The Lancet.

[16]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[17]  D. Morton,et al.  Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[19]  P. Borgstein,et al.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. , 1998, Annals of surgery.

[20]  R. Roumen,et al.  Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  P. Borgstein.  Intradermal blue dye to identify sentinel lymph node in breast cancer , 1997, The Lancet.

[22]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[23]  A E Giuliano,et al.  Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Thompson,et al.  Mammary lymphoscintigraphy in breast cancer. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[26]  N. Cascinelli,et al.  Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary Nodes , 1985, Annals of surgery.

[27]  U. Veronesi,et al.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer , 1983, Cancer.

[28]  L. Bennett,et al.  Cutaneous lymphoscintigraphy in malignant melanoma. , 1983, Seminars in nuclear medicine.

[29]  R. Foster,et al.  Staging of breast cancer: a new rationale for internal mammary node biopsy. , 1981, Archives of surgery.

[30]  D. Morton,et al.  Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. , 1977, Surgical forum.

[31]  U. Veronesi,et al.  Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five‐year results of an international cooperative study , 1976, Cancer.

[32]  E. Vendrell-Torné,et al.  Study of normal mammary lymphatic drainage using radioactive isotopes. , 1972, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  R. Turner-Warwick.  The lymphatics of the breast , 1959, The British journal of surgery.

[34]  L. Larsson,et al.  The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal Au198. , 1955, Acta radiologica.